Background illustration for clinical trials search

Paid Clinical Trials Fort Worth

Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of STP938 (Dencatistat) in Advanced Solid Tumours

for
Solid Tumor
Location: Dallas TX, San Antonio TX, St. Petersburg FL
Sponsor: Step Pharma, SAS

Sex: All

Age: 18+

Code: NCT06297525

Phase 1, Recruiting

Asciminib Roll-over Study

for
Chronic Myelogenous Leukemia,
Location: Dallas TX, Houston TX, St Louis MO, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 7 - 70+

Code: NCT04877522

Phase 4, Recruiting

Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone

for
Carcinoma, Squamous Cell
Location: Dallas TX, Houston TX, Little Rock AR, Aurora CO,
Sponsor: Introgen Therapeutics

Sex: All

Age: 18+

Code: NCT00041626

Phase 3, Recruiting

Tailored Exercise Training Study Among Adults With HFpEF

for
HFpEF - Heart Failure With Preserved Ejection Fraction,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT07223242

Phase 2, Phase 3, Recruiting

BP1001-A in Patients With Advanced or Recurrent Solid Tumors

for
Solid Tumor, Adult, Carcinoma, Ovarian Epithelial,
Location: Dallas TX, Houston TX, Detroit MI, Silver Spring MD
Sponsor: Bio-Path Holdings, Inc.

Sex: All

Age: 18+

Code: NCT04196257

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

SW-682 in Advanced Solid Tumors

for
Advanced Solid Tumor, Mesothelioma, Malignant
Location: Dallas TX, Houston TX, Scottsdale AZ, Cleveland OH,
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany

Sex: All

Age: 18+

Code: NCT06251310

Phase 1, Recruiting

First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Dallas TX, Los Angeles CA
Sponsor: 1200 Pharma, LLC

Sex: All

Age: 18+

Code: NCT05103046

Phase 1, Recruiting

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

for
Solid Tumors, ER+ Breast Cancer,
Location: Dallas TX, St Louis MO, Salt Lake City UT, Detroit MI
Sponsor: Jacobio Pharmaceuticals Co., Ltd.

Sex: All

Age: 18+

Code: NCT05490472

Phase 1, Phase 2, Recruiting

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Dallas TX, Plano TX, Austin TX, Houston TX,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07207811

Phase 3, Recruiting

The Feasibility of Cream for Treatment of Neonatal Hypoglycemia

for
Neonatal Hypoglycemia
Location: McKinney TX
Sponsor: Baylor Research Institute

Sex: All

Age: 0

Code: NCT07217483

Recruiting

The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Dallas TX, San Antonio TX, Fairway KS, Louisville KY,
Sponsor: Impact Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04768868

Phase 1, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: DeSoto TX, Carrollton TX, Dallas TX, Allen TX,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190209

Phase 3, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: Dallas TX, Wylie TX, Denison TX, Austin TX,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190222

Phase 3, Recruiting

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

for
Advanced Cancer, Metastatic Cancer
Location: Dallas TX, Rochester MN, Chicago IL, Phoenix AZ,
Sponsor: Qurient Co., Ltd.

Sex: All

Age: 18+

Code: NCT05394103

Phase 1, Phase 2, Recruiting

A Study of ASP1002 in Adults for Treatment of Solid Tumors

for
Advanced Solid Tumors
Location: Dallas TX, Iowa City IA, Louisville KY, Saint Paul MN,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT05719558

Phase 1, Recruiting

HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors

for
Solid Tumors, Adult
Location: Dallas TX
Sponsor: HighField Biopharmaceuticals Corporation

Sex: All

Age: 18 - 70+

Code: NCT05861895

Phase 1, Recruiting

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Dallas TX, San Antonio TX, Houston TX, Nashville TN,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06040541

Phase 1, Recruiting

Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai

for
Breast Cancer Awareness
Location: Frisco TX
Sponsor: Feminai

Sex: Female

Age: 25 - 70+

Code: NCT07220863

Recruiting

Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors

for
Solid Tumor, Relapsed Solid Neoplasm, Refractory Tumor
Location: Dallas TX, Sioux Falls SD, Fairfax VA
Sponsor: Sorrento Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04900519

Phase 1, Recruiting

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

for
Platinum-resistant Ovarian Cancer, Testicular Cancer,
Location: Dallas TX, Little Rock AR, Omaha NE, Denver CO,
Sponsor: Context Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06515613

Phase 1, Recruiting